FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116731538> ?p ?o ?g. }

• W2116731538 endingPage "540" @default.
• W2116731538 startingPage "537" @default.
• W2116731538 abstract "Colorectal tumours that are wild type for KRAS are often sensitive to EGFR blockade, but almost always develop resistance within several months of initiating therapy. The mechanisms underlying this acquired resistance to anti-EGFR antibodies are largely unknown. This situation is in marked contrast to that of small-molecule targeted agents, such as inhibitors of ABL, EGFR, BRAF and MEK, in which mutations in the genes encoding the protein targets render the tumours resistant to the effects of the drugs. The simplest hypothesis to account for the development of resistance to EGFR blockade is that rare cells with KRAS mutations pre-exist at low levels in tumours with ostensibly wild-type KRAS genes. Although this hypothesis would seem readily testable, there is no evidence in pre-clinical models to support it, nor is there data from patients. To test this hypothesis, we determined whether mutant KRAS DNA could be detected in the circulation of 28 patients receiving monotherapy with panitumumab, a therapeutic anti-EGFR antibody. We found that 9 out of 24 (38%) patients whose tumours were initially KRAS wild type developed detectable mutations in KRAS in their sera, three of which developed multiple different KRAS mutations. The appearance of these mutations was very consistent, generally occurring between 5 and 6 months following treatment. Mathematical modelling indicated that the mutations were present in expanded subclones before the initiation of panitumumab treatment. These results suggest that the emergence of KRAS mutations is a mediator of acquired resistance to EGFR blockade and that these mutations can be detected in a non-invasive manner. They explain why solid tumours develop resistance to targeted therapies in a highly reproducible fashion." @default.
• W2116731538 created "2016-06-24" @default.
• W2116731538 creator A5012950907 @default.
• W2116731538 creator A5029348961 @default.
• W2116731538 creator A5039492614 @default.
• W2116731538 creator A5045016516 @default.
• W2116731538 creator A5050789569 @default.
• W2116731538 creator A5053304093 @default.
• W2116731538 creator A5053505951 @default.
• W2116731538 creator A5059462255 @default.
• W2116731538 creator A5066160076 @default.
• W2116731538 creator A5067936223 @default.
• W2116731538 creator A5071328253 @default.
• W2116731538 creator A5072858943 @default.
• W2116731538 creator A5081956768 @default.
• W2116731538 date "2012-06-01" @default.
• W2116731538 modified "2023-10-18" @default.
• W2116731538 title "The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers" @default.
• W2116731538 cites W1966001093 @default.
• W2116731538 cites W1975940378 @default.
• W2116731538 cites W1985090267 @default.
• W2116731538 cites W1985264867 @default.
• W2116731538 cites W1990376228 @default.
• W2116731538 cites W1991472738 @default.
• W2116731538 cites W1998971866 @default.
• W2116731538 cites W2006168411 @default.
• W2116731538 cites W2009031936 @default.
• W2116731538 cites W2015438948 @default.
• W2116731538 cites W2018106070 @default.
• W2116731538 cites W2039932938 @default.
• W2116731538 cites W2041919461 @default.
• W2116731538 cites W2066330900 @default.
• W2116731538 cites W2094556422 @default.
• W2116731538 cites W2106789440 @default.
• W2116731538 cites W2107693250 @default.
• W2116731538 cites W2111712086 @default.
• W2116731538 cites W2121389354 @default.
• W2116731538 cites W2123370218 @default.
• W2116731538 cites W2128507784 @default.
• W2116731538 cites W2139799027 @default.
• W2116731538 cites W2141674733 @default.
• W2116731538 cites W2153909311 @default.
• W2116731538 cites W2155311724 @default.
• W2116731538 cites W2163235555 @default.
• W2116731538 cites W2170343590 @default.
• W2116731538 cites W4235642752 @default.
• W2116731538 doi "https://doi.org/10.1038/nature11219" @default.
• W2116731538 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3436069" @default.
• W2116731538 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22722843" @default.
• W2116731538 hasPublicationYear "2012" @default.
• W2116731538 type Work @default.
• W2116731538 sameAs 2116731538 @default.
• W2116731538 citedByCount "1460" @default.
• W2116731538 countsByYear W21167315382012 @default.
• W2116731538 countsByYear W21167315382013 @default.
• W2116731538 countsByYear W21167315382014 @default.
• W2116731538 countsByYear W21167315382015 @default.
• W2116731538 countsByYear W21167315382016 @default.
• W2116731538 countsByYear W21167315382017 @default.
• W2116731538 countsByYear W21167315382018 @default.
• W2116731538 countsByYear W21167315382019 @default.
• W2116731538 countsByYear W21167315382020 @default.
• W2116731538 countsByYear W21167315382021 @default.
• W2116731538 countsByYear W21167315382022 @default.
• W2116731538 countsByYear W21167315382023 @default.
• W2116731538 crossrefType "journal-article" @default.
• W2116731538 hasAuthorship W2116731538A5012950907 @default.
• W2116731538 hasAuthorship W2116731538A5029348961 @default.
• W2116731538 hasAuthorship W2116731538A5039492614 @default.
• W2116731538 hasAuthorship W2116731538A5045016516 @default.
• W2116731538 hasAuthorship W2116731538A5050789569 @default.
• W2116731538 hasAuthorship W2116731538A5053304093 @default.
• W2116731538 hasAuthorship W2116731538A5053505951 @default.
• W2116731538 hasAuthorship W2116731538A5059462255 @default.
• W2116731538 hasAuthorship W2116731538A5066160076 @default.
• W2116731538 hasAuthorship W2116731538A5067936223 @default.
• W2116731538 hasAuthorship W2116731538A5071328253 @default.
• W2116731538 hasAuthorship W2116731538A5072858943 @default.
• W2116731538 hasAuthorship W2116731538A5081956768 @default.
• W2116731538 hasBestOaLocation W21167315382 @default.
• W2116731538 hasConcept C104317684 @default.
• W2116731538 hasConcept C121608353 @default.
• W2116731538 hasConcept C143065580 @default.
• W2116731538 hasConcept C170493617 @default.
• W2116731538 hasConcept C2778332735 @default.
• W2116731538 hasConcept C2778468042 @default.
• W2116731538 hasConcept C2781187634 @default.
• W2116731538 hasConcept C2994294914 @default.
• W2116731538 hasConcept C501734568 @default.
• W2116731538 hasConcept C502942594 @default.
• W2116731538 hasConcept C526805850 @default.
• W2116731538 hasConcept C54355233 @default.
• W2116731538 hasConcept C71924100 @default.
• W2116731538 hasConcept C86803240 @default.
• W2116731538 hasConceptScore W2116731538C104317684 @default.
• W2116731538 hasConceptScore W2116731538C121608353 @default.
• W2116731538 hasConceptScore W2116731538C143065580 @default.
• W2116731538 hasConceptScore W2116731538C170493617 @default.

• next